What a TMS Treatment Journal Is and What It Is Not
Repetitive transcranial magnetic stimulation (rTMS) is described by the National Institute of Mental Health as a noninvasive therapy that uses repeated magnetic pulses to stimulate targeted brain circuits. NIMH notes that typical sessions last approximately 3 to 40 minutes and that a typical course is five sessions per week for four to six weeks, while accelerated protocols can differ. Because your experience between visits may include sensations, sleep changes, and mood shifts, a short consistent record gives your clinician useful context without asking you to interpret it.[source]
What to Record: A Practical Tracking Table
The table below lists items worth writing down, grounded in what NIMH describes as common short-term effects and typical session features. Experiences vary by device, protocol, and individual plan, so treat the table as a starting point and use the fields your care team finds useful.[source]
| Field | What to note | Why it helps |
|---|---|---|
| Date and session number | Day, time, and which session in the course | Gives your care team a timeline for any pattern |
| Session notes | Session length or protocol details if the clinic shares them | NIMH describes sessions of roughly 3 to 40 minutes; details vary by plan |
| Scalp or headache sensations | What you felt, when it started, how long it lasted | NIMH lists scalp discomfort and mild headache as common short-term effects |
| Facial or jaw muscle sensations | Where and when you noticed it | NIMH lists facial or jaw muscle sensations as a common short-term effect |
| Lightheadedness or dizziness | Whether it was brief and what you were doing | NIMH lists brief lightheadedness and dizziness as common short-term effects |
| Sleep | Hours slept and how rested you felt | The APA/NNDC consensus source notes sleep deprivation is relevant to safety screening |
| Mood and energy | A brief daily note using a simple scale you choose | Gives your clinician context for follow-up conversation |
| Medicines or substances | Any change or new substance, with the date | The APA/NNDC source describes screening for medicines or substances that may alter seizure threshold |
| Questions | Anything you want to raise at the next visit | Turns notes into a focused conversation |
How to Log Side Effects Without Self-Diagnosing
When you notice a sensation, describe it rather than interpret it. A simple method is to note four things: what you felt, when it started relative to the session, how long it lasted, and whether it changed what you could do that day. Then bring the note to your care team. NIMH lists scalp discomfort, facial or jaw muscle sensations, mild headache, brief lightheadedness, and dizziness as common short-term effects, and notes that seizure is possible but uncommon when expert safety guidance is followed. Your journal cannot determine whether a symptom is expected or concerning; that judgment belongs to your clinician.[source]
The FDA's Class II special-controls guidance for rTMS systems identifies risks and controls that include seizure, scalp discomfort or burn, effects on other medical devices, hearing effects, and electromagnetic interference, and it emphasizes labeling, trained use, and patient- and device-specific contraindications and warnings. That is why a descriptive note is more useful than a self-assigned label: your care team can compare what you recorded against the labeling and your individual plan.[source]
A neutral way to describe a sensation
- Name what you felt Use plain words such as pressure, ache, tingling, or lightheadedness.
- Note the timing Record when it started relative to the session and how long it lasted.
- Note the impact Write whether it changed your usual activities that day.
- Bring it to your care team Share the note at your next contact rather than deciding what it means.
Tracking Mood, Sleep and Daily Function Between Sessions
Brief daily notes on mood, energy, sleep duration and quality, and changes in routine give your care team context for follow-up. Use a consistent simple scale you choose, such as 1 to 5 for mood and energy, and keep entries short. The APA and NNDC consensus recommendations note that sleep deprivation and other medical factors are relevant to pre-treatment safety screening, so sleep notes can be worth sharing. The journal itself does not establish treatment response or predict outcomes; it only helps you describe what you observed.[source][source]
Recording Medicines, Substances and Safety-Relevant Changes
The APA and NNDC consensus recommendations describe pre-treatment screening for medicines or substances that may alter seizure threshold, along with neurologic and seizure history and metal or implanted-device history. Noting changes between visits helps your care team reassess safety. Do not start, stop, or change any medicine based on your journal; raise changes with your clinician, who can advise on what is appropriate for you.[source]
Turning Your Journal Into Questions for the Next Visit
Before a follow-up appointment, review your notes and write a short question list. Useful questions include whether a logged sensation is expected, whether sleep changes matter for your plan, and what the next steps in your course look like. NIMH describes a typical course of five sessions per week for four to six weeks while accelerated protocols can differ, so questions about schedule and course length are reasonable to raise. Answers should come from your treating clinician rather than from the journal.[source][source]
What a Journal Cannot Tell You
A journal cannot confirm whether TMS is working, predict remission, judge device suitability, or replace evaluation and current device labeling. A 2025 systematic review comparing accelerated with standard or sham rTMS found heterogeneous results and no definitive conclusion, so personal notes should not be used to compare protocols or claim one is superior. Share your notes with your care team and let them interpret them alongside your clinical picture.[source][source]
Next steps
For current appointment, location, or contact information, visit the official website.[source]
Frequently Asked Questions
Do I need a special app or template for a TMS treatment journal?
No. A notebook, a phone note, or a printed table can all work. What matters is consistent, dated, descriptive entries rather than a specific product. No supplied evidence shows that any particular app improves TMS outcomes.
Should I record every headache or scalp sensation during TMS?
It helps to note sensations with timing, duration, and impact on your daily activity, then bring them to your care team. NIMH describes scalp discomfort, mild headache, and brief dizziness as common short-term effects. Your journal cannot determine whether a sensation is expected or concerning.
Can my journal show whether TMS is working?
No. A journal is a communication aid, not a measure of response, and no supplied evidence supports using personal logs to judge treatment effectiveness. Share your notes with your treating clinician, who can assess your progress.
What should I do if I notice a new or worsening symptom between visits?
Contact your care team for guidance rather than adjusting anything based on your journal. They can advise on next steps for your situation.
Should I write down medicine changes in my TMS journal?
Yes. Note changes and new substances to discuss at follow-up, because the APA and NNDC consensus source describes screening for medicines or substances that may affect seizure threshold. Do not change medicines without clinician direction.
References
- APA and NNDC consensus recommendations for clinical rTMS in major depressive disorder — pmc.ncbi.nlm.nih.gov
- Comparison between accelerated and standard or sham rTMS in depression: 2025 systematic review — pubmed.ncbi.nlm.nih.gov
- FDA Class II special controls for rTMS systems used for major depressive disorder — www.fda.gov
- NIMH brain stimulation therapies: rTMS patient evidence summary — www.nimh.nih.gov
- Official website — tms-heal.com
Leave a Reply